Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-05

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for LEVETIRACETAM from Torrent Pharmaceuticals Limited. This reflects a supplemental approval under theANDA process …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)